Minnesota's Solventum sells purification business to Thermo Fisher for $4.1 billion
M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson said in a news release that the sale,
Shares of Thermo Fisher Scientific Inc. TMO rose 1.10% to $528.96 Friday, on what proved to be an all-around positive trading ...
1don MSN
We recently published a list of 10 Best Affordable Dividend Stocks to Buy According to Hedge Funds. In this article, we are ...
Thermo Fisher Scientific is deploying a corrective field action to replace the defective heater. The heater in the unit may ...
Shares of Thermo Fisher Scientific Inc. TMO shed 1.89% to $523.23 Thursday, on what proved to be an all-around rough trading ...
Hosted on MSN3d
Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz SegmentThermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides ...
Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Thermo Fisher (TMO – Research Report), ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry. The multi-center, prospective registry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback